Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Newsletter 2022

Newsletter February 2022: Opioid misuse after surgery: can I do something about it?

Tzima Maria, MD, MSc, PhD(c), Trainee Anaesthesiologist, Ippokrateio General Hospital of Thessaloniki, Greece. Marc Giménez-Milà. Consultant anaesthetist. Hospital CLINIC Barcelona. Spain


Dear Editor,

Daliya et al 1 have recently published a retrospective observational cohort study about an opioid prescription at postoperative discharge following intermediate or major general surgery. The study included 499 patients operated during March 2019 in 14 hospitals in England. The intermediate and major groups had a similar proportion of opioid prescriptions at the discharge of 21% and 21.6% respectively. Of note, 107 patients were discharged with regular opioids and 78 patients had no written deprescribing advice on discharge. The authors conclude that there is a lack of adherence to postoperative analgesia guidelines and poor prescribing practice were noted.

Opioid misuse is a matter of issue since the 19th century when England and China fought twice for their trade.2 Laudanum was known as ‘white opium’ and was used without a prescription, for the treatment of cough, diarrhoea and pain. Nowadays, opioid use has much more alarming dimensions, with increased rates of fatal or non-fatal doses and behavioural problems, when it comes to children or adolescents. In the US, 50.000 opioid-related deaths are reported annually and postoperative prescription of opioids is a major cause.3-11

Opioids are commonly used during and after surgery to minimise and control pain to facilitate rehabilitation.3-11 However, their use may be related to serious complications.  Increased rates of postoperative pain and nausea, urine retention, ileus, dizziness, respiratory depression are common side effects in the postoperative period, that may prolong hospital stay and cost. Hyperalgesia and tolerance are two opposite effects, which also are related to opioid use. Patients who used opioids before surgery are also more susceptible to further opioid misuse.

Multimodal anaesthesia is gaining ground and opioid free anaesthesia (OFA) is being used more and more.4 Different pharmacological agents are used to offer adequate conditions for surgery, such as dexmedetomidine, ketamine, lidocaine, clonidine, paracetamol, NSAIDs, betablockers, gabapentinoids and regional anaesthesia techniques. The synergistic effect of all the above drugs contributes to antinociception. Fast-track protocols in different surgical specialities include OFA or opioid-sparing techniques to reduce hospital length of stay and cost.

Healthcare workers should optimise pain management, in order to reduce opioid-related side-effects, by educating families about pain management. 3

In conclusion, opioids are a useful tool in the anaesthetists’ tools but their widespread use has led to misuse with serious complications. We, as anaesthetists are obliged to modulate surgical nociceptive stimulus either with opioids or with the other coadjuvants as described above. We should not forget that bad control of acute postoperative pain is a well-recognised risk factor for developing chronic pain. OFA should never be accompanied by uncontrolled acute pain with the excuse of avoiding postoperative opioid dependency behaviours. Sometimes, perfect is the enemy of good.


  1. Daliya, P., Adiamah, A., Roslan, F et al. Anaesthesia, 76: 1367-1376. https://doi.org/10.1111/anae.15460
  2. https://en.wikipedia.org/wiki/Opium_Wars
  3. Lawal OD, Gold J, Murthy A, et al. JAMA Netw Open.2020;3(6):e207367.
  4. Hah JM, Bateman BT, Ratliff J, et al, Anesth Analg. 2017;125(5):1733-1740.
  5. Neuman MD, Bateman BT, Wunsch H. Lancet. 2019;393(10180):1547-1557.
  6. Thiesset HF, Schliep KC, Stokes SM et al, J Surg Res. 2020 Aug; 252:200-205
  7. Harbaugh CM, Lee JS, Hu HM et al, Pediatrics. 2018 Jan;141(1): e2017-2439.
  8. Rucinski K, Cook JL. J Orthop. 2020 Jan 21; 20:154-159. doi: 10.1016/j.jor.2020.01.020.
  9. Yorkgitis BK, Brat GA. Am J Surg. 2018 Apr;215(4):707-711.
  10. Namiranian K, Siglin J, Sorkin JD, et al,. J Subst Abuse Treat. 2020 Feb; 109:8-13.
  11. Kelley-Quon LI, Kirkpatrick MG, Ricca RLet al, JAMA Surg. 2021 Jan 1;156(1):76-90..

Related news

See all news